name: 'cellular-senescence-agent'
description: 'AI-powered analysis of cellular senescence for aging research, cancer therapy response, and senolytic drug development.'
measurable_outcome: Execute skill workflow successfully with valid output within 15 minutes.
allowed-tools:
- read_file
- run_shell_command
Cellular Senescence Agent
The Cellular Senescence Agent provides comprehensive AI-driven analysis of cellular senescence signatures for aging research, cancer biology, and senolytic therapeutic development.
When to Use This Skill
- When identifying senescent cells in tissue or single-cell data.
- To analyze senescence-associated secretory phenotype (SASP).
- For predicting senolytic drug sensitivity.
- When studying therapy-induced senescence in cancer.
- To assess senescence burden in aging and disease.
Core Capabilities
Senescence Scoring: Calculate senescence signatures from transcriptomic data.
SASP Profiling: Characterize senescence-associated secretory phenotype composition.
Single-Cell Detection: Identify senescent cells in scRNA-seq data.
Senolytic Prediction: Predict sensitivity to senolytic drugs.
Tissue Aging: Assess senescence burden across tissues.
Cancer Senescence: Analyze therapy-induced senescence.
Senescence Markers
| Category |
Markers |
Detection |
| Cell cycle |
p16INK4a, p21CIP1, p53 |
Expression, IHC |
| SA-β-gal |
GLB1 (lysosomal) |
Activity assay |
| SASP |
IL-6, IL-8, MMP3, PAI-1 |
Expression, secretion |
| DNA damage |
γH2AX, 53BP1 foci |
Immunofluorescence |
| Morphology |
Enlarged, flattened |
Imaging |
| Epigenetic |
SAHF, SAHMs |
Chromatin marks |
Workflow
Input: Bulk or single-cell RNA-seq, proteomics, imaging data.
Signature Scoring: Apply senescence gene signatures.
SASP Analysis: Profile secretory phenotype.
Cell Identification: Flag senescent cells (single-cell).
Senolytic Prediction: Match to drug sensitivity profiles.
Burden Estimation: Quantify senescence load.
Output: Senescence scores, SASP profile, drug recommendations.
Example Usage
User: "Analyze senescence signatures in this aging tissue dataset and identify senolytic candidates."
Agent Action:
python3 Skills/Longevity_Aging/Cellular_Senescence_Agent/senescence_analyzer.py \
--rnaseq tissue_expression.tsv \
--singlecell tissue_scrnaseq.h5ad \
--signatures fridman_sasp,reactome_senescence \
--senolytic_prediction true \
--tissue liver \
--output senescence_report/
Senescence Gene Signatures
| Signature |
Genes |
Application |
| Fridman (2017) |
CDKN1A, CDKN2A, SERPINE1... |
Pan-senescence |
| SenMayo |
125 genes |
Tissue senescence |
| SASP Core |
IL6, IL8, CXCL1, MMP1... |
Secretory phenotype |
| p16/p21 pathway |
CDKN2A, CDKN1A, MDM2... |
Cell cycle arrest |
SASP Components
Pro-inflammatory:
- Interleukins: IL-1α/β, IL-6, IL-8
- Chemokines: CXCL1, CXCL2, CCL2
- Growth factors: TGF-β, VEGF
Matrix Remodeling:
- MMPs: MMP1, MMP3, MMP10
- Serpins: PAI-1 (SERPINE1)
Effects on Microenvironment:
- Paracrine senescence spread
- Immune cell recruitment
- ECM remodeling
- Tumor promotion (chronic) vs suppression (acute)
Senolytic Drugs
| Drug |
Target |
Clinical Status |
| Dasatinib |
Src/tyrosine kinases |
Trials (with Q) |
| Quercetin |
PI3K, serpins |
Trials (with D) |
| Navitoclax |
BCL-2/BCL-xL |
Trials |
| Fisetin |
Multiple |
Early trials |
| UBX1325 |
BCL-xL |
Phase 2 (macular) |
AI/ML Components
Senescence Classifier:
- Multi-gene signature scoring
- ML classifiers on expression
- Single-cell senescence probability
Drug Response:
- GDSC/CCLE senescence sensitivity
- SASP-drug correlations
- Synergy predictions
Aging Clock Integration:
- Epigenetic age correlation
- Transcriptomic age
- Senescence-aging relationships
Cancer Applications
Therapy-Induced Senescence (TIS):
- Chemotherapy, radiation
- CDK4/6 inhibitors (palbociclib)
- Dual outcomes: tumor suppression vs SASP-driven recurrence
Senescence + Senolytics:
- Induce senescence → clear with senolytics
- "One-two punch" approach
- Clinical trials ongoing
Prerequisites
- Python 3.10+
- Gene signature tools (GSVA, ssGSEA)
- Single-cell analysis (Scanpy)
- Drug response databases
Related Skills
- Single_Cell - For scRNA-seq analysis
- Cancer_Metabolism_Agent - For metabolic senescence
- Tumor_Microenvironment - For SASP effects
Research Applications
- Aging Research: Quantify senescence burden
- Cancer Therapy: Monitor TIS response
- Drug Development: Senolytic efficacy
- Fibrosis: Senescence in fibrotic disease
- Regeneration: Senescence in tissue repair
Author
AI Group - Biomedical AI Platform
1---2name: cellular-senescence-agent3description: <!--4---5<!--6# COPYRIGHT NOTICE7# This file is part of the "Universal Biomedical Skills" project.8# Copyright (c) 2026 MD BABU MIA, PhD <md.babu.mia@mssm.edu>9# All Rights Reserved.10#11# This code is proprietary and confidential.12# Unauthorized copying of this file, via any medium is strictly prohibited.13#14# Provenance: Authenticated by MD BABU MIA1516-->1718---19name: 'cellular-senescence-agent'20description: 'AI-powered analysis of cellular senescence for aging research, cancer therapy response, and senolytic drug development.'21measurable_outcome: Execute skill workflow successfully with valid output within 15 minutes.22allowed-tools:23 - read_file24 - run_shell_command25---262728# Cellular Senescence Agent2930The **Cellular Senescence Agent** provides comprehensive AI-driven analysis of cellular senescence signatures for aging research, cancer biology, and senolytic therapeutic development.3132## When to Use This Skill3334* When identifying senescent cells in tissue or single-cell data.35* To analyze senescence-associated secretory phenotype (SASP).36* For predicting senolytic drug sensitivity.37* When studying therapy-induced senescence in cancer.38* To assess senescence burden in aging and disease.3940## Core Capabilities41421. **Senescence Scoring**: Calculate senescence signatures from transcriptomic data.43442. **SASP Profiling**: Characterize senescence-associated secretory phenotype composition.45463. **Single-Cell Detection**: Identify senescent cells in scRNA-seq data.47484. **Senolytic Prediction**: Predict sensitivity to senolytic drugs.49505. **Tissue Aging**: Assess senescence burden across tissues.51526. **Cancer Senescence**: Analyze therapy-induced senescence.5354## Senescence Markers5556| Category | Markers | Detection |57|----------|---------|-----------|58| Cell cycle | p16INK4a, p21CIP1, p53 | Expression, IHC |59| SA-β-gal | GLB1 (lysosomal) | Activity assay |60| SASP | IL-6, IL-8, MMP3, PAI-1 | Expression, secretion |61| DNA damage | γH2AX, 53BP1 foci | Immunofluorescence |62| Morphology | Enlarged, flattened | Imaging |63| Epigenetic | SAHF, SAHMs | Chromatin marks |6465## Workflow66671. **Input**: Bulk or single-cell RNA-seq, proteomics, imaging data.68692. **Signature Scoring**: Apply senescence gene signatures.70713. **SASP Analysis**: Profile secretory phenotype.72734. **Cell Identification**: Flag senescent cells (single-cell).74755. **Senolytic Prediction**: Match to drug sensitivity profiles.76776. **Burden Estimation**: Quantify senescence load.78797. **Output**: Senescence scores, SASP profile, drug recommendations.8081## Example Usage8283**User**: "Analyze senescence signatures in this aging tissue dataset and identify senolytic candidates."8485**Agent Action**:86```bash87python3 Skills/Longevity_Aging/Cellular_Senescence_Agent/senescence_analyzer.py \88 --rnaseq tissue_expression.tsv \89 --singlecell tissue_scrnaseq.h5ad \90 --signatures fridman_sasp,reactome_senescence \91 --senolytic_prediction true \92 --tissue liver \93 --output senescence_report/94```9596## Senescence Gene Signatures9798| Signature | Genes | Application |99|-----------|-------|-------------|100| Fridman (2017) | CDKN1A, CDKN2A, SERPINE1... | Pan-senescence |101| SenMayo | 125 genes | Tissue senescence |102| SASP Core | IL6, IL8, CXCL1, MMP1... | Secretory phenotype |103| p16/p21 pathway | CDKN2A, CDKN1A, MDM2... | Cell cycle arrest |104105## SASP Components106107**Pro-inflammatory**:108- Interleukins: IL-1α/β, IL-6, IL-8109- Chemokines: CXCL1, CXCL2, CCL2110- Growth factors: TGF-β, VEGF111112**Matrix Remodeling**:113- MMPs: MMP1, MMP3, MMP10114- Serpins: PAI-1 (SERPINE1)115116**Effects on Microenvironment**:117- Paracrine senescence spread118- Immune cell recruitment119- ECM remodeling120- Tumor promotion (chronic) vs suppression (acute)121122## Senolytic Drugs123124| Drug | Target | Clinical Status |125|------|--------|-----------------|126| Dasatinib | Src/tyrosine kinases | Trials (with Q) |127| Quercetin | PI3K, serpins | Trials (with D) |128| Navitoclax | BCL-2/BCL-xL | Trials |129| Fisetin | Multiple | Early trials |130| UBX1325 | BCL-xL | Phase 2 (macular) |131132## AI/ML Components133134**Senescence Classifier**:135- Multi-gene signature scoring136- ML classifiers on expression137- Single-cell senescence probability138139**Drug Response**:140- GDSC/CCLE senescence sensitivity141- SASP-drug correlations142- Synergy predictions143144**Aging Clock Integration**:145- Epigenetic age correlation146- Transcriptomic age147- Senescence-aging relationships148149## Cancer Applications150151**Therapy-Induced Senescence (TIS)**:152- Chemotherapy, radiation153- CDK4/6 inhibitors (palbociclib)154- Dual outcomes: tumor suppression vs SASP-driven recurrence155156**Senescence + Senolytics**:157- Induce senescence → clear with senolytics158- "One-two punch" approach159- Clinical trials ongoing160161## Prerequisites162163* Python 3.10+164* Gene signature tools (GSVA, ssGSEA)165* Single-cell analysis (Scanpy)166* Drug response databases167168## Related Skills169170* Single_Cell - For scRNA-seq analysis171* Cancer_Metabolism_Agent - For metabolic senescence172* Tumor_Microenvironment - For SASP effects173174## Research Applications1751761. **Aging Research**: Quantify senescence burden1772. **Cancer Therapy**: Monitor TIS response1783. **Drug Development**: Senolytic efficacy1794. **Fibrosis**: Senescence in fibrotic disease1805. **Regeneration**: Senescence in tissue repair181182## Author183184AI Group - Biomedical AI Platform185186187<!-- AUTHOR_SIGNATURE: 9a7f3c2e-MD-BABU-MIA-2026-MSSM-SECURE -->